The Foundation for Research and Technology – Hellas (FORTH) was founded in 1983.
It is the premier multidisciplinary research institution in Greece with well-organized facilities, highly qualified personnel and a reputation as a top-level research institution worldwide.
Institutes
Research Groups
Active Projects
People
Research Highlights
FORTH attracts new funding from the European Research Council
Two ERC Starting Grants totaling approximately 3 million euros, were awarded to Dr. Anna Sydorenko and Dr. Konstantina Kalfa, post-doctoral researchers at the Institute for Mediterranean Studies of the Foundation for Research and Technology-Hellas (FORTH).
International scientific collaboration reveals how intermittent fasting regulates ageing through autophagy
Recent research at the Institute of Molecular Biology and Biotechnology (IMBB) of the Foundation for Research and Technology-Hellas (FORTH), at the Paris Cité University, and at the University of Graz, published today in the premier international science periodical Nature Cell Biology, sheds light on the mechanism through which spermidine regulates
Latest News
FORTH hosts the International Conference on Pervasive Computing Technologies for Healthcare, 17 to 18 September 2024
The 18th EAI International Conference on Pervasive Computing Technologies for Healthcare will take place at the facilities of FORTH in Heraklion, Crete from 17 to 18 September 2024, with the active participation and co-organization of the Institute of Computer Science of FORTH, and the Center for Research & Technology Hellas.
IACM FORTH Summer Graduate School on Mathematics of General Relativity and Fluids
The Summer School took place at the premises of FORTH at Heraklion, Crete, Greece, from July 22nd to August 2nd 2024
Events
Events Calendar
February
March
April
FORTH's responses to COVID-19 pandemic
The Foundation for Research and Technology-Hellas (FORTH) and its Institutes have been made available to the State and Public Health Authorities, in order to contribute to the common effort to address the pandemic of COVID-19, with their top-level infrastructure and expertise.
